Clinical Trial

Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Study acronym: CHACRY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to perform a French multicenter prospective interventional study in order to assess the feasibility and safety of ovarian hyperstimulation for oocyte / embryo cryopreservation in young women with breast cancer. The oncologic and reproductive benefit / risk ratio will be investigated in the oncology and reproductive area.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2016-08-12; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2024-06-03
Status change: Not Yet Recruiting → Recruiting 2017-01-11
Trial Details
NCT Number NCT02871167
Lead Sponsor Centre Oscar Lambret
Collaborators: University Hospital, Lille, National Cancer Institute, France, University Hospital, Montpellier
Conditions Breast Cancer
Enrollment 140 participants
Start Date 2016-12
Primary Completion 2024-06-05 (estimated)
Study Completion 2034-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-18